The European Medicines Agency said the portal will enable consultations with medical device expert panels that can promote faster access to new technologies.
With the thumbs up from CHMP, the Opvido-Yervoy combo now moves forward to the European Commission ... from the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA).
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance” or the "Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...
Cindy Perettie; Executive Vice President of Kite; Gilead Sciences Inc. Geoffrey Meacham; Analyst; Citi. Terence Flynn; Analyst; Morgan Stanley. Timothy Anderson; Analyst; BofA Glo ...
Boca Raton, Florida Wednesday, February 12, 2025, 16:00 Hrs [IST] ...
In today's edition of the Capitals, read about the upcoming German elections, another chapter of Meloni vs. ICC, and so much more.
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024. "Gilead delivered another exceptionally ...
Ascendis Pharma (ASND) reported its fourth-quarter 2024 earnings, highlighting a significant revenue increase and a positive market reaction. The company posted total revenue of €173.9 million for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback